Log In
Print this Print this

HyperAcute Lung, tergenpumatucel-L

  Manage Alerts
Collapse Summary General Information
Company NewLink Genetics Corp.
DescriptionAlpha 1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II/III
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsSecond-line treatment of advanced non-small cell lung cancer (NSCLC); Treat advanced non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today